合成路线1
该中间体在本合成路线中的序号:
(XIV) The condensation of (XIII) with N-protected L-alanine (XIV) by means of PyBrOP and diethylisopropylamine in DMF gives the cyclic tripeptide (XV), which after deprotection with TFA is condensed with the protected tripeptide (XVI) by means of EDC and HOBT to provide the cyclic hexapeptide (XVII). Finally, this compound is cyclized by hydrolysis of the methyl ester with LiOH in THF/methanol/water, deprotection of the amino group with TFA and cyclization with DPPA and NaHCO3 in DMF.
【1】
Bigot, A.; et al.; Total synthesis of an antitumor agent RA-VII via an efficient preparation of cycloisodityrosine. J Org Chem 1999, 64, 17, 6283.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XIII) |
26446 |
methyl (9S,12S)-4-methoxy-12-(methylamino)-11-oxo-2-oxa-10-azatricyclo[12.2.2.1(3,7)]nonadeca-1(16),3(19),4,6,14,17-hexaene-9-carboxylate
|
|
C21H24N2O5 |
详情 |
详情
|
(XIV) |
26450 |
Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid |
15761-38-3 |
C8H15NO4 |
详情 | 详情
|
(XV) |
26447 |
methyl (9S,12S)-12-[[(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl](methyl)amino]-4-methoxy-11-oxo-2-oxa-10-azatricyclo[12.2.2.1(3,7)]nonadeca-1(16),3(19),4,6,14,17-hexaene-9-carboxylate
|
|
C29H37N3O8 |
详情 |
详情
|
(XVI) |
26448 |
(6R,9S,12S)-12-(4-methoxybenzyl)-2,2,6,9,11-pentamethyl-4,7,10-trioxo-3-oxa-5,8,11-triazatridecan-13-oic acid
|
|
C22H33N3O7 |
详情 |
详情
|
(XVII) |
26449 |
methyl (9S,12S)-4-methoxy-12-[[(2S,5S,8S,11R)-5-(4-methoxybenzyl)-2,6,8,11,15,15-hexamethyl-4,7,10,13-tetraoxo-14-oxa-3,6,9,12-tetraazahexadec-1-anoyl](methyl)amino]-11-oxo-2-oxa-10-azatricyclo[12.2.2.1(3,7)]nonadeca-1(16),3(19),4,6,14,17-hexaene-9-carboxylate |
|
C46H60N6O12 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(II) Coupling of ethyl glyoxylate derivative (I) with Boc-L-Alanine (II) by means of EDC and DMAP in DMF provides compound (III), whose ethyl ester is subjected to saponification by treatment with NaOH in EtOH to furnish carboxylic acid (IV). Condensation of (IV) with methoxyamine (NH2OMe) in THF/H2O yields methoxyimino acetic acid derivative (V), which is then coupled to pivaloyloxymethyl 7-amino-3-cephem-4-carboxylate (VI) in CH2Cl2 by means of phosphorus oxychloride (POCl3) in DMF/EtOAc and N-trimethylsilylacetamide to give compound (VII). Finally, the desired compound is obtained after treatment of (VII) with TFA and anisole in CH2Cl2 for Boc removal . Alternatively, methoxyimino acetic acid derivative (V) can be converted into intermediate (VII) by coupling with 7-amino-3-cephem-4-carboxylic acid (VIII) by means of POCl3 in DMF/EtOAc and N-trimethylsilylacetamide in CH2Cl2 to provide derivative (IX), followed by condensation with iodomethyl pivalate (X) by means of potassium acetate in DMF.
【1】
Muro, H.; Kasai, M.; Hatano, s.; Nishimura, K.-I.; Nishizawa, S.; Kakeya, N. (Kyoto Pharmaceutical Industries, Ltd.); Cephalosporin cpds. and production thereof. EP 0497978; JP 1991204883; US 5389625; WO 9106549 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
49506 |
Ethyl 2-amino-4-thiazoleglyoxylate
|
|
C7H8N2O3S |
详情 |
详情
|
(II) |
26450 |
Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid |
15761-38-3 |
C8H15NO4 |
详情 | 详情
|
(III) |
49507 |
ethyl 2-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-1,3-thiazol-4-yl]-2-oxoacetate
|
|
C15H21N3O6S |
详情 |
详情
|
(IV) |
49508 |
2-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-1,3-thiazol-4-yl]-2-oxoacetic acid
|
|
C13H17N3O6S |
详情 |
详情
|
(V) |
49509 |
2-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-1,3-thiazol-4-yl]-2-(methoxyimino)acetic acid
|
|
C14H20N4O6S |
详情 |
详情
|
(VI) |
49510 |
[(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
C13H18N2O5S |
详情 |
详情
|
(VII) |
49511 |
[(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-[[2-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-1,3-thiazol-4-yl]-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
C27H36N6O10S2 |
详情 |
详情
|
(VIII) |
49512 |
(6R,7R)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
|
C7H8N2O3S |
详情 |
详情
|
(IX) |
49513 |
(6R,7R)-7-[[2-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-1,3-thiazol-4-yl]-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
|
C21H26N6O8S2 |
详情 |
详情
|
(X) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(II) Coupling of pivaloyloxymethyl 7-amino-3-cephem-4-carboxylate (VI) and methoxyimino acetic acid derivative (XI) by means of POCl3 and pyridine in CH2Cl2 gives compound (XII) (alternatively (XII) can be obtained by condensation of ceftizoxime (CZX) (XIII) with iodomethyl pivalate (X) in N,N-dimethylacetamide (DMAc) in the presence of dicyclohexylamine). Coupling of (XII) with Boc-L-alanine (II) by means of EDC and DMAP in CH2Cl2 gives intermediate (VII), whose Boc protecting group is removed by treatment with either HCl/isopropanol in formic acid or TFA and anisole in CH2Cl2.
Yet another strategy can be followed, involving the coupling of pivaloyloxymethyl 7-amino-3-cephem-4-carboxylate (VI) with derivative (XIV) by means of Et3N in N,N-dimethylacetamide.
【1】
Shirahase, H.; Hatano, S.; Yoshimi, A.; Kitagawa, M.; Kasai, M.; Nishimura, K.; Kakeya, N.; AS-924, a novel bifunctional prodrug of ceftizoxime. J Antibiot 1999, 52, 5, 491.
|
【2】
Kasai, M.; et al.; AS-924, a novel orally active bifunctional prodrug of ceftizoxime. Synthesis and relationship between physicochemical properties and oral absorption. Chem Pharm Bull 1999, 47, 8, 1081.
|
【3】
Muro, H.; Kasai, M.; Hatano, s.; Nishimura, K.-I.; Nishizawa, S.; Kakeya, N. (Kyoto Pharmaceutical Industries, Ltd.); Cephalosporin cpds. and production thereof. EP 0497978; JP 1991204883; US 5389625; WO 9106549 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
26450 |
Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid |
15761-38-3 |
C8H15NO4 |
详情 | 详情
|
(VI) |
49510 |
[(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
C13H18N2O5S |
详情 |
详情
|
(VII) |
49511 |
[(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-[[2-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-1,3-thiazol-4-yl]-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
C27H36N6O10S2 |
详情 |
详情
|
(X) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
(XI) |
24737 |
2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetic acid
|
65872-41-5 |
C6H7N3O3S |
详情 | 详情
|
(XII) |
49514 |
[(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
C19H23N5O7S2 |
详情 |
详情
|
(XIII) |
49515 |
(6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
|
C13H13N5O5S2 |
详情 |
详情
|
(XIV) |
49516 |
2-(2-[[(2S)-2-aminopropanoyl]amino]-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl chloride
|
|
C9H11ClN4O3S |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(XII) Amino acid (XI) was then coupled with N-Boc-L-alanine (XII) using EDC and HOBt to furnish amide (XIII), and its Boc group was subsequently cleaved with HCl in dioxan, yielding (XIV). A second coupling with N-Boc-L-alanine (XII), followed by acid deprotection gave (XV) as the hydrochloride salt. Conversion to the title methanesulfonate salt was carried out by liberation of the base with NaHCO3 and subsequent treatment with MsOH acetone.
【1】
Brighty, K.E. (Pfizer Inc.); Anti-bacterial azabicyclo quinolone carboxylic acids. US 5229396 .
|
【2】
Brighty, K.E. (Pfizer Inc.); Azabicyclo quinolone and naphthyridone carboxylic acids. US 5164402 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
43089 |
7-[(1R,5S)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid
|
|
C20H15F3N4O3 |
详情 |
详情
|
(XII) |
26450 |
Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid |
15761-38-3 |
C8H15NO4 |
详情 | 详情
|
(XIII) |
43090 |
7-[(1R,5S)-6-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid
|
|
C28H28F3N5O6 |
详情 |
详情
|
(XIV) |
43091 |
7-((1R,5S)-6-[[(2S)-2-aminopropanoyl]amino]-3-azabicyclo[3.1.0]hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid
|
|
C23H20F3N5O4 |
详情 |
详情
|
(XV) |
43092 |
7-[(1R,5S)-6-[((2S)-2-[[(2S)-2-aminopropanoyl]amino]propanoyl)amino]-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid
|
|
C26H25F3N6O5 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(II) The coupling of 2-amino-4-methylthiophene-3-carboxylic acid ethyl ester (I) with N-(tert-butoxycarbonyl)-L-alanine (II) by means of isobutyl chloroformate and NMM, followed by cyclization with triphenylphosphine in CCl4 gives the thieno-oxazinone (III), which is deprotected with TFA yielding (IV) with a free amino group that is acylated with cinnamic acid by means of DEC and DIEA.
【1】
Tew, D.G.; Pinto, I.L.S.M.; Jarvest, R.L.; Jennings, L.J.; Dabrowski, C.E.; Fernandez, A.V.; Lavery, P.; Inhibition of herpes proteases and antiviral activity of 2-substituted thieno[2,3-d]oxazinones. Bioorg Med Chem Lett 1999, 9, 3, 443.
|
【2】
Jarvest, R.L.; Jennings, L.J.A.; Pinto, I.L. (SmithKline Beecham plc); Thienoxazinone derivs. useful as antiviral agents. WO 9727200 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29512 |
ethyl 2-amino-4-methyl-3-thiophenecarboxylate
|
43088-42-2 |
C8H11NO2S |
详情 | 详情
|
(II) |
26450 |
Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid |
15761-38-3 |
C8H15NO4 |
详情 | 详情
|
(III) |
28659 |
tert-butyl (1S)-1-(5-methyl-4-oxo-4H-thieno[2,3-d][1,3]oxazin-2-yl)ethylcarbamate
|
|
C14H18N2O4S |
详情 |
详情
|
(IV) |
28660 |
2-[(1S)-1-aminoethyl]-5-methyl-4H-thieno[2,3-d][1,3]oxazin-4-one
|
|
C9H10N2O2S |
详情 |
详情
|
(V) |
10449 |
(Z)-3-Phenyl-2-propenoic acid
|
621-82-9 |
C9H8O2 |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) The coupling of 2-amino-4-methylthiophene-3-carboxylic acid ethyl ester (I) with N-(tert-butoxycarbonyl)-L-alanine (II) by means of isobutyl chloroformate and NMM, followed by cyclization with triphenylphosphine in CCl4 gives the thieno-oxazinone (III), which is deprotected with TFA yielding (IV) with a free amino group that is acylated with 3-(5-bromothien-2-yl)-2(E)-propenoic acid by means of DEC and DIEA.
【1】
Tew, D.G.; Pinto, I.L.S.M.; Jarvest, R.L.; Jennings, L.J.; Dabrowski, C.E.; Fernandez, A.V.; Lavery, P.; Inhibition of herpes proteases and antiviral activity of 2-substituted thieno[2,3-d]oxazinones. Bioorg Med Chem Lett 1999, 9, 3, 443.
|
【2】
Jarvest, R.L.; Jennings, L.J.A.; Pinto, I.L. (SmithKline Beecham plc); Thienoxazinone derivs. useful as antiviral agents. WO 9727200 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29512 |
ethyl 2-amino-4-methyl-3-thiophenecarboxylate
|
43088-42-2 |
C8H11NO2S |
详情 | 详情
|
(II) |
26450 |
Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid |
15761-38-3 |
C8H15NO4 |
详情 | 详情
|
(III) |
28659 |
tert-butyl (1S)-1-(5-methyl-4-oxo-4H-thieno[2,3-d][1,3]oxazin-2-yl)ethylcarbamate
|
|
C14H18N2O4S |
详情 |
详情
|
(IV) |
28660 |
2-[(1S)-1-aminoethyl]-5-methyl-4H-thieno[2,3-d][1,3]oxazin-4-one
|
|
C9H10N2O2S |
详情 |
详情
|
(V) |
29513 |
(E)-3-(5-bromo-2-thienyl)-2-propenoic acid
|
|
C7H5BrO2S |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(II) The cyclization of 2-amino-4-methylthiophene-3-carboxylic acid (I) with N-(tert-butoxycarbonyl)-L-alanine (II), by means of 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide (DEC) and HOBT in DMF gives the protected thienooxazinone (III), which is deprotected with trifluoroacetic acid in dichloro methane yielding 2-(1(S)-aminoethyl)-5-methyl-4H-thieno[2,3-d][1,3]oxazin-4-one (IV). Finally, this compound is acylated with 4-oxo-4-phenyl-2(E)-butenoic acid (VI) by means of DEC and diisopropylethylamine in DMF.
【1】
Jarvest, R.L.; Pinto, I.L.; Clarke, B.; et al.; Inhibition of human cytomegalovirus protease by enedione derivatives of thieno[2,3-d]oxazinones through a novel dual acylation/alkylation mechanism. Bioorg Med Chem Lett 1999, 9, 3, 449.
|
【2】
Jarvest, R.L.; Jennings, L.J.A.; Pinto, I.L. (SmithKline Beecham plc); Thienoxazinone derivs. useful as antiviral agents. WO 9727200 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
28658 |
2-amino-4-methyl-3-thiophenecarboxylic acid
|
|
C6H7NO2S |
详情 |
详情
|
(II) |
26450 |
Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid |
15761-38-3 |
C8H15NO4 |
详情 | 详情
|
(III) |
28659 |
tert-butyl (1S)-1-(5-methyl-4-oxo-4H-thieno[2,3-d][1,3]oxazin-2-yl)ethylcarbamate
|
|
C14H18N2O4S |
详情 |
详情
|
(IV) |
28660 |
2-[(1S)-1-aminoethyl]-5-methyl-4H-thieno[2,3-d][1,3]oxazin-4-one
|
|
C9H10N2O2S |
详情 |
详情
|
(V) |
28661 |
(E)-4-oxo-4-phenyl-2-butenoic acid
|
583-06-2 |
C10H8O3 |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(I) The compound was prepared by solid phase peptide synthesis on a p-methylbenzhydrylamine resin. Attachment of Boc-L-alanine (I) afforded resin (II). Subsequent deprotection of the Boc group of (II) gave the alanine-linked resin (III). Coupling of (III) with Boc-L-proline (IV), followed by Boc group cleavage yielded the dipeptide resin (V). Further coupling of (V) with N-Boc-(2S,3R)-3-amino-2-hydroxy-5-methylhexanoic acid (VI) furnished the tripeptide resin (VI). Finally, deprotection of the Boc group of (VI) and simultaneous cleavage from the resin by treatment with HF provided the title tripeptide amide.
【1】
Maggiora, L.L.; Simmons, W.H.; Orawski, A.T.; Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme. J Med Chem 1999, 42, 13, 2394.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26450 |
Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid |
15761-38-3 |
C8H15NO4 |
详情 | 详情
|
(II) |
35168 |
tert-butyl (1S)-2-amino-1-methyl-2-oxoethylcarbamate
|
|
C8H16N2O3 |
详情 |
详情
|
(III) |
35169 |
(2S)-2-aminopropanamide
|
|
C3H8N2O |
详情 |
详情
|
(IV) |
16734 |
(2S)-1-(tert-butoxycarbonyl)tetrahydro-1H-pyrrole-2-carboxylic acid; N-alpha-t-BOC-L-proline; (2S)-1-(tert-butoxycarbonyl)-2-pyrrolidinecarboxylic acid
|
|
C10H17NO4 |
详情 |
详情
|
(V) |
35170 |
(2S)-N-[(1S)-2-amino-1-methyl-2-oxoethyl]-2-pyrrolidinecarboxamide
|
|
C8H15N3O2 |
详情 |
详情
|
(VI) |
35171 |
(2S,3R)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-5-methylhexanoic acid
|
|
C12H23NO5 |
详情 |
详情
|
(VII) |
35172 |
tert-butyl (1R)-1-[(1S)-2-[(2S)-2-([[(1S)-2-amino-1-methyl-2-oxoethyl]amino]carbonyl)pyrrolidinyl]-1-hydroxy-2-oxoethyl]-3-methylbutylcarbamate
|
|
C20H36N4O6 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(VI) Coupling of 2,5-dimethylphenol (I) with methyl 3,3-dimethylacrylate (II) by means of methanesulfonic acid yields dihydrocoumarin (III), which is reduced with LiAlH4 in THF to provide alcohol (IV). Selective O-protection at the primary hydroxy group of (IV) with tert-butyldimethylsilyl chloride (TBDMS-Cl) and Et3N in dichloromethane affords compound (V), which is then coupled with Boc-Ala-OH (VI) by means of EDC and DMAP in dichloromethane to give ester (VII). O-Deprotection of (VII) with HOAc in THF/H2O furnishes alcohol (VIII), which is then oxidized by means of pyridinium chlorochromate (PCC) in dichloromethane, giving aldehyde (IX). Compound (IX) is further oxidized with NaClO2 and sodium sulfite (Na2CO3) in H2O and NaH2PO4 in acetonitrile to yield propionic acid (X), whose Boc group is removed by treatment with TFA in dichloromethane, furnishing hydrochloride (XI). Coupling of (XI) with PEG thiazolidinethione (T-PEG) (XII) (1) by means of DIEA in dichloromethane gives PEG-alaninyl derivative (XIII), which is finally condensed with daunorubicin hydrochloride (XIV) by means of EDC · HCl, HOBt and NMM in dichloromethane to afford the target product.
【1】
Greenwald, R.B.; et al.; PEG thiazolidine-2-thione, a novel reagent for facile protein modification: Conjugation of bovine hemoglobin. Bioconjugate Chem 1996, 7, 6, 638.
|
【2】
Choe, Y.H.; Shum, K.; Conover, C.D.; Greenwald, R.B.; Wu, D.; Royzen, M.; Drug delivery systems based on trimethyl lock lactonization: Poly(ethylene glycol) prodrugs of amino-containing compounds. J Med Chem 2000, 43, 3, 475.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
46786 |
3,5-dimethylphenol
|
108-68-9 |
C8H10O |
详情 | 详情
|
(II) |
24113 |
methyl 3-methyl-2-butenoate; Methyl 3,3-dimethylacrylate |
924-50-5 |
C6H10O2 |
详情 | 详情
|
(III) |
46787 |
4,4,5,7-tetramethyl-2-chromanone
|
|
C13H16O2 |
详情 |
详情
|
(IV) |
46788 |
2-(3-hydroxy-1,1-dimethylpropyl)-3,5-dimethylphenol
|
|
C13H20O2 |
详情 |
详情
|
(V) |
46789 |
2-(3-[[tert-butyl(dimethyl)silyl]oxy]-1,1-dimethylpropyl)-3,5-dimethylphenol
|
|
C19H34O2Si |
详情 |
详情
|
(VI) |
26450 |
Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid |
15761-38-3 |
C8H15NO4 |
详情 | 详情
|
(VII) |
46790 |
2-(3-[[tert-butyl(dimethyl)silyl]oxy]-1,1-dimethylpropyl)-3,5-dimethylphenyl (2S)-2-[(tert-butoxycarbonyl)amino]propanoate
|
|
C27H47NO5Si |
详情 |
详情
|
(VIII) |
46791 |
2-(3-hydroxy-1,1-dimethylpropyl)-3,5-dimethylphenyl (2S)-2-[(tert-butoxycarbonyl)amino]propanoate
|
|
C21H33NO5 |
详情 |
详情
|
(IX) |
46792 |
2-(1,1-dimethyl-3-oxopropyl)-3,5-dimethylphenyl (2S)-2-[(tert-butoxycarbonyl)amino]propanoate
|
|
C21H31NO5 |
详情 |
详情
|
(X) |
46793 |
3-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]oxy)-4,6-dimethylphenyl]-3-methylbutyric acid
|
|
C21H31NO6 |
详情 |
详情
|
(XI) |
46794 |
3-(2-[[(2S)-2-aminopropanoyl]oxy]-4,6-dimethylphenyl)-3-methylbutyric acid
|
|
C16H23NO4 |
详情 |
详情
|
(XII) |
46795 |
2-(2-methoxyethoxy)-1-(2-thioxo-1,3-thiazolidin-3-yl)-1-ethanone
|
|
C8H13NO3S2 |
详情 |
详情
|
(XIII) |
46796 |
3-[2-[((2S)-2-[[2-(2-methoxyethoxy)acetyl]amino]propanoyl)oxy]-4,6-dimethylphenyl]-3-methylbutyric acid
|
|
C21H31NO7 |
详情 |
详情
|
(XIV) |
18598 |
2-methyl-8-quinolinol
|
826-81-3 |
C10H9NO |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(XIII) Azepinone (X) was obtained by cyclization of Boc-L-lysine (IX) in the presence of NaHCO3 and BOP reagent. Subsequent alkylation of the lactam nitrogen of (X) with benzyl bromoacetate (XI) afforded (XII). After Boc deprotection of (XII) with trifluoroacetic acid, coupling with Boc-L-alanine (XIII) gave dipeptide (XIV). This was subjected to a further deprotection and coupling sequence with Boc-L-tryptophan (XV) to give tripeptide (XVI), and then with Boc-L-glutamine (XVII), yielding (XVIII). Acid deprotection of the Boc group of (XVIII), followed by coupling with p-hydroxyphenylpropionic acid (XIX) provided the peptide amide (XX).
【1】
Cristau, M.; et al.; Synthesis and biological evaluation of bombesin constrained analogues. J Med Chem 2000, 43, 12, 2356.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IX) |
42809 |
(2S)-6-amino-2-[(tert-butoxycarbonyl)amino]hexanoic acid
|
|
C11H22N2O4 |
详情 |
详情
|
(X) |
42810 |
L-(-)-N-alpha-Boc-amino-epsilon-caprolactam; tert-butyl (3S)-2-oxoazepanylcarbamate
|
76944-95-1 |
C11H20N2O3 |
详情 | 详情
|
(XI) |
12869 |
benzyl 2-bromoacetate
|
5437-45-6 |
C9H9BrO2 |
详情 | 详情
|
(XII) |
42811 |
benzyl 2-[(3S)-3-[(tert-butoxycarbonyl)amino]-2-oxoazepanyl]acetate
|
n/a |
C20H28N2O5 |
详情 | 详情
|
(XIII) |
26450 |
Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid |
15761-38-3 |
C8H15NO4 |
详情 | 详情
|
(XIV) |
42812 |
benzyl 2-[(3S)-3-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-2-oxoazepanyl]acetate
|
|
C23H33N3O6 |
详情 |
详情
|
(XV) |
16114 |
N-alpha-t-BOC-L-tryptophan; (2S)-2-[(tert-butoxycarbonyl)amino]-3-(1H-indol-3-yl)propionic acid
|
13139-14-5 |
C16H20N2O4 |
详情 | 详情
|
(XVI) |
42813 |
benzyl 2-[(3S)-3-[((2S)-2-[[(2S)-2-[(tert-butoxycarbonyl)amino]-3-(1H-indol-3-yl)propanoyl]amino]propanoyl)amino]-2-oxoazepanyl]acetate
|
|
C34H43N5O7 |
详情 |
详情
|
(XVII) |
31820 |
(2S)-5-amino-2-[(tert-butoxycarbonyl)amino]-5-oxopentanoic acid
|
13726-85-7 |
C10H18N2O5 |
详情 | 详情
|
(XVIII) |
42814 |
benzyl 2-((3S)-3-[[(2S,5S,8S)-8-(3-amino-3-oxopropyl)-5-(1H-indol-3-ylmethyl)-2,12,12-trimethyl-4,7,10-trioxo-11-oxa-3,6,9-triazatridec-1-anoyl]amino]-2-oxoazepanyl)acetate
|
|
C39H51N7O9 |
详情 |
详情
|
(XIX) |
25691 |
3-(4-hydroxyphenyl)propionic acid
|
501-97-3 |
C9H10O3 |
详情 | 详情
|
(XX) |
42815 |
benzyl 2-[(3S)-3-[((2S)-2-[[(2S)-2-[((2S)-5-amino-2-[[3-(4-hydroxyphenyl)propanoyl]amino]-5-oxopentanoyl)amino]-3-(1H-indol-3-yl)propanoyl]amino]propanoyl)amino]-2-oxoazepanyl]acetate
|
|
C43H51N7O9 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(I) The reaction of N-(tert-butoxycarbonyl)-L-alanine (I) with biphenyl-4-carbaldehyde (II) by means of oxalyl chloride and ZnCl2 or TsOH gives the oxazolidinone (III), which is alkylated with 4-bromobenzyl bromide (IV) and LHMDS in THF, yielding the alkylated compound (V). The opening of the oxazolidinone ring of (V) with LiOMe and NaHSO3 affords the aminopropionic ester (VI), which is cyclized again with 3,5-dichloroaniline (VII) by means of NaOMe in refluxing toluene to provide imidazolidinedione (VIII). Finally, this compound is methylated with MeI, NaOH and tetrabutylammonium bisulfate to give the target compound.
【1】
Farina, V.; Napolitano, E.; Crystallization-induced asymmetric transformations and self-regeneration of stereocenters (SROSC): Enantiospecific synthesis of alpha-benzylalanine and hydantoin BIRT-377. Tetrahedron Lett 2001, 42, 18, 3231.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26450 |
Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid |
15761-38-3 |
C8H15NO4 |
详情 | 详情
|
(II) |
28446 |
[1,1'-biphenyl]-4-carbaldehyde
|
3218-36-8 |
C13H10O |
详情 | 详情
|
(III) |
47938 |
tert-butyl (2S,4S)-2-[1,1'-biphenyl]-4-yl-4-methyl-5-oxo-1,3-oxazolidine-3-carboxylate
|
|
C21H23NO4 |
详情 |
详情
|
(IV) |
16109 |
1-bromo-4-(bromomethyl)benzene; 4-Bromobenzyl bromide
|
589-15-1 |
C7H6Br2 |
详情 | 详情
|
(V) |
47939 |
tert-butyl (2S,4S)-2-[1,1'-biphenyl]-4-yl-4-(4-bromobenzyl)-4-methyl-5-oxo-1,3-oxazolidine-3-carboxylate
|
|
C28H28BrNO4 |
详情 |
详情
|
(VI) |
47940 |
methyl (2S)-3-(4-bromophenyl)-2-[(tert-butoxycarbonyl)amino]-2-methylpropanoate
|
|
C16H22BrNO4 |
详情 |
详情
|
(VII) |
26542 |
3,5-dichloroaniline
|
626-43-7 |
C6H5Cl2N |
详情 | 详情
|
(VIII) |
47933 |
(5R)-5-(4-bromobenzyl)-3-(3,5-dichlorophenyl)-5-methyl-2,4-imidazolidinedione
|
|
C17H13BrCl2N2O2 |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(I) The reaction of N-(tert-butoxycarbonyl)-L-alanine (I) with benzaldehyde dimethylacetal (II) by means of SOCl2 and ZnCl2 gives the oxazolidinone (III), which is alkylated with 4-bromobenzyl bromide (IV) and KHMDS in THF to yield the alkylated compound (V). The opening of the oxazolidinone ring of (V) with HBr/HOAc, followed by esterification with EtOH/HCl, affords the aminopropionic ester (VI), which is cyclized again with 3,5-dichlorophenyl isocyanate (VII) by means of Na2CO3 to provide imidazolidinedione (VIII). Finally, this compound is methylated with Me-I and NaHMDS to give the target compound.
【1】
Kapadia, S.R.; et al.; An improved synthesis of chiral alpha-(4-bromobenzyl)alanine ethyl ester and its application to the synthesis of LFA-1 antagonist BIRT-377. J Org Chem 2001, 66, 5, 1903.
|
【2】
Emeigh, J.E.; et al.; Small molecule antagonists of LFA-1 mediated cell adhesion. 221st ACS Natl Meet (April 1 2001, San Diego) 2001, Abst MEDI 256.
|
【3】
Bormann, B.J.; Frye, L.L.; Wu, J.-P.; Kelly, T.A. (Boehringer Ingelheim Pharmaceuticals Inc.); Small molecules useful in the treatment of inflammatory disease. EP 0966447; WO 9839303 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26450 |
Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid |
15761-38-3 |
C8H15NO4 |
详情 | 详情
|
(II) |
27515 |
Methoxy(phenyl)methyl methyl ether; Dimethylacetal benzaldehyde; Benzaldehyde dimethylacetal
|
1125-88-8 |
C9H12O2 |
详情 | 详情
|
(III) |
47934 |
tert-butyl (2S,4S)-4-methyl-5-oxo-2-phenyl-1,3-oxazolidine-3-carboxylate
|
|
C15H19NO4 |
详情 |
详情
|
(IV) |
16109 |
1-bromo-4-(bromomethyl)benzene; 4-Bromobenzyl bromide
|
589-15-1 |
C7H6Br2 |
详情 | 详情
|
(V) |
47935 |
tert-butyl (2S,4S)-4-(4-bromobenzyl)-4-methyl-5-oxo-2-phenyl-1,3-oxazolidine-3-carboxylate
|
|
C22H24BrNO4 |
详情 |
详情
|
(VI) |
47936 |
ethyl (2S)-2-amino-3-(4-bromophenyl)-2-methylpropanoate
|
|
C12H16BrNO2 |
详情 |
详情
|
(VII) |
47937 |
1,3-dichloro-5-isocyanatobenzene; 3,5-dichlorophenyl isocyanate
|
|
C7H3Cl2NO |
详情 |
详情
|
(VIII) |
47933 |
(5R)-5-(4-bromobenzyl)-3-(3,5-dichlorophenyl)-5-methyl-2,4-imidazolidinedione
|
|
C17H13BrCl2N2O2 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(VIII) The condensation between 4-(acetylamino)thiophenol (I) and 5-chloro-2-nitroaniline (II) produced the diaryl sulfide (III). Nitro group reduction in (III) employing SnCl2 gave the phenylenediamine (IV), which was cyclized to the benzimidazole (VI) upon treatment with N,N'-bis(methoxycarbonyl)-S-methylisothiourea (V). Hydrolysis of the acetamido group of (VI) with HCl in MeOH afforded aniline (VII). This was acylated with N-Boc-alanine (VIII) in the presence of EDC to yield amide (IX). The N-Boc protecting group of (IX) was finally removed by treatment with trifluoroacetic acid.
【1】
Lewis, G.S.; Nolan, J.; Davis, P.D.; Naylor, M.A.; Thomson, P.; Hill, S.A.; Benzimidazole carbamates: A new structural class of vascular targeting agents. Proc Amer Assoc Cancer Res 2001, 42, Abst 2000.
|
【2】
Davis, P.D. (Angiogene Pharmaceuticals Ltd.); Benzimidazole vascular damaging agents. EP 1140078; WO 0041669 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
34329 |
N-(4-sulfanylphenyl)acetamide
|
1126-81-4 |
C8H9NOS |
详情 | 详情
|
(II) |
15709 |
5-chloro-2-nitrophenylamine; 5-chloro-2-nitroaniline
|
1635-61-6 |
C6H5ClN2O2 |
详情 | 详情
|
(III) |
51869 |
N-[4-[(3-amino-4-nitrophenyl)sulfanyl]phenyl]acetamide
|
|
C14H13N3O3S |
详情 |
详情
|
(IV) |
51870 |
N-[4-[(3,4-diaminophenyl)sulfanyl]phenyl]acetamide
|
|
C14H15N3OS |
详情 |
详情
|
(V) |
28696 |
methyl (Z)-[(methoxycarbonyl)amino](methylsulfanyl)methylidenecarbamate
|
|
C6H10N2O4S |
详情 |
详情
|
(VI) |
51871 |
methyl 5-[[4-(acetamido)phenyl]sulfanyl]-1H-benzimidazol-2-ylcarbamate
|
|
C17H16N4O3S |
详情 |
详情
|
(VII) |
51872 |
methyl 5-[(4-aminophenyl)sulfanyl]-1H-benzimidazol-2-ylcarbamate
|
|
C15H14N4O2S |
详情 |
详情
|
(VIII) |
26450 |
Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid |
15761-38-3 |
C8H15NO4 |
详情 | 详情
|
(IX) |
51873 |
methyl 5-[[4-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)phenyl]sulfanyl]-1H-benzimidazol-2-ylcarbamate
|
|
C23H27N5O5S |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(II) Coupling between methyl 2-amino-5-phenylpentanoate (I) and N-Boc-alanine (II) affords dipeptide (III). Deprotection of (III) with trifluoroacetic acid yields amine (IV), which is then acylated with (S)-3,5-difluoromandelic acid (V), producing amide (VI). Finally, ester group reduction using LiBH4 leads to the desired alcohol.
【1】
Garofalo, A.W.; et al.; A series of C-terminal amino alcohol dipeptide Abeta inhibitors. 28th Natl Med Chem Symp (June 8 2002, San Diego) 2002, Abst 11.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
58436 |
methyl (2S)-2-amino-5-phenylpentanoate
|
|
C12H17NO2 |
详情 |
详情
|
(II) |
26450 |
Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid |
15761-38-3 |
C8H15NO4 |
详情 | 详情
|
(III) |
58437 |
methyl (2S)-2-({(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl}amino)-5-phenylpentanoate
|
|
C20H30N2O5 |
详情 |
详情
|
(IV) |
58438 |
methyl (2S)-2-{[(2S)-2-aminopropanoyl]amino}-5-phenylpentanoate
|
|
C15H22N2O3 |
详情 |
详情
|
(V) |
58439 |
(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoic acid
|
|
C8H6F2O3 |
详情 |
详情
|
(VI) |
58440 |
methyl (2S)-2-[((2S)-2-{[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]amino}propanoyl)amino]-5-phenylpentanoate
|
|
C23H26F2N2O5 |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(IV) Racemic amine (I) can be resolved by the following alternative procedures: An alternative procedure to compound (VII) begins by condensating amine (II) with N-Boc-L-alanine (IV) in the presence of HOBt.H2O, DIEA and EDC in THF to yield the N-Boc-L-alaninamide derivative (IX) . Similarly, the hydrochloride of amine (II) reacts with N-Boc-L-alanine (IV) in the presence of HOBt.H2O, DIEA and EDC in THF . Intermediate (IX) is then deprotected with either HCl in EtOAc or 1,4-dioxane , or concentrated HCl , and the resulting amine (VII) is obtained as the free base or employed without isolation, respectively. Finally, either hydrochloride (VII) or the nonisolated species obtained from compound (IX) is condensed with 2(S)-hydroxy-3-methylbutyric acid (X) by means of HOBt.H2O, NMM and EDC.HCl in H2O to give semagacestat . Under related conditions, the free base of (VII) couples with acid (XI) in the presence of HOBt.H2O, DIEA and EDC in THF . Alternatively, silylation of 2(S)-hydroxy-3-methylbutyric acid (X) with HMDS in the presence of (NH4)2SO4 at reflux gives trimethylsilyl 3-methyl-2(S)-(trimethylsilyloxy) butanoate (XI), which is first reacted with (COCl)2 in the presence of DMF in CH2Cl2 and then with the mesylate salt (VIII) by means of NMM in CH2Cl2 .
【1】
Koenig, T.M., Nissen, J.S., Mitchell, D. (Eli Lilly and Company). Lactam compound. EP 1345955, JP 2005538031, WO 2002040508. |
【2】
Audia, J.E., John, V., Latimer, L.H., Tung, J.S., Nissen, J.S., Thorsett, E.D., McDaniel, S.L. (Eli Lilly and Company; Elan Pharmaceuticals, Inc.). Lactam compound. JP 2004517090, WO 2002047671. |
【3】
Koenig, T.M., Audia, J.E., Mitchell, D., Aikins, J.A., Buccilli, L.A., Engel,G.L., McDaniel, S.L. (Eli Lilly and Company). Lactam compound. CA 2425497, EP 1353910, JP 2004521084, WO 2002040451. |
【4】
Audia, J.E., Diseroad, B.A., Varghese, J. et al. (Eli Lilly and Company).Lactam compound. US 2007299053, US 7468365. |
【5】
Mitchell, D., Hay, L.A., Koenig, T.M., McDaniel, S., Nissen, J.S., Audia, J.E.Classical and dynamic resolution of 1-amino-3-methyl-1,3,4,5-tetrahydrobenzo[d]azepin-2-one. Tetrahedron Asymmetry 2005, 16(23): 3814-9. |
【6】
Pu, Y.J., Vaid, R.K., Boini, S.K., Towsley, R.W., Doecke, C.W., Mitchell, D. A practical method for functionalized peptide or amide bond formation in aqueous-ethanol media with EDC as activator. Org Process Res Dev 2009, 13(2): 310-4. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
69307 |
1-amino-3-methyl-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one |
|
C11H14N2O |
详情 |
详情
|
(II) |
69308 |
1(S)-amino-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-2-one |
|
C11H14N2O |
详情 |
详情
|
(III) |
69309 |
1(S)-amino-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-2-one |
|
C11H14N2O |
详情 |
详情
|
(IV) |
26450 |
Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid |
15761-38-3 |
C8H15NO4 |
详情 | 详情
|
(V) |
13423 |
1-[(Chlorocarbonyl)oxy]-2-methylpropane; Isobutyl chloroformate;isobutyl carbonochloridate |
543-27-1 |
C5H9ClO2 |
详情 | 详情
|
(VI) |
69310 |
(S)-2-((tert-butoxycarbonyl)amino)propanoic (isobutyl carbonic) anhydride |
|
C13H23NO6 |
详情 |
详情
|
(VII) |
69311 |
(S)-2-amino-N-((R)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[d]azepin-1-yl)propanamide hydrochloride |
|
C14H19N3O2.HCl |
详情 |
详情
|
(VIII) |
69312 |
(S)-2-amino-N-((R)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[d]azepin-1-yl)propanamide methanesulfonate |
|
C14H19N3O2.CH4O3S |
详情 |
详情
|
(IX) |
69313 |
tert-butyl ((S)-1-(((R)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[d]azepin-1-yl)amino)-1-oxopropan-2-yl)carbamate |
|
C19H27N3O4 |
详情 |
详情
|
(X) |
69314 |
2(S)-hydroxy-3-methylbutyric acid |
|
C5H10O3 |
详情 |
详情
|
(XI) |
69315 |
(S)-trimethylsilyl 3-methyl-2-((trimethylsilyl)oxy)butanoate |
|
C11H26O3Si2 |
详情 |
详情
|